BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9681971)

  • 21. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland.
    Capen CC
    Toxicol Pathol; 1997; 25(1):39-48. PubMed ID: 9061850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for and possible mechanisms of non-genotoxic carcinogenesis in the rodent thyroid.
    Thomas GA; Williams ED
    Mutat Res; 1991 Jun; 248(2):357-70. PubMed ID: 2046691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promotion of thyroid tumors in rats by pregnenolone-16alpha-carbonitrile (PCN) and polychlorinated biphenyl (PCB).
    Vansell NR; Muppidi JR; Habeebu SM; Klaassen CD
    Toxicol Sci; 2004 Sep; 81(1):50-9. PubMed ID: 15201439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mode of action for induction of thyroid gland tumors by Pyrethrins in the rat.
    Finch JM; Osimitz TG; Gabriel KL; Martin T; Henderson WJ; Capen CC; Butler WH; Lake BG
    Toxicol Appl Pharmacol; 2006 Aug; 214(3):253-62. PubMed ID: 16626768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: implications for thyroid gland neoplasia.
    McClain RM
    Toxicol Pathol; 1989; 17(2):294-306. PubMed ID: 2675280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action.
    Dellarco VL; McGregor D; Berry SC; Cohen SM; Boobis AR
    Crit Rev Toxicol; 2006; 36(10):793-801. PubMed ID: 17118729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland.
    Curran PG; DeGroot LJ
    Endocr Rev; 1991 May; 12(2):135-50. PubMed ID: 2070777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of Ethylene Thiourea (CAS: 96-45-7) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1992 Mar; 388():1-256. PubMed ID: 12637971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promotion of N-methyl-N-nitrosourea-induced thyroid tumors by iodine deficiency in F344/NCr rats.
    Ohshima M; Ward JM
    J Natl Cancer Inst; 1984 Jul; 73(1):289-96. PubMed ID: 6588234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid circadian timing: roles in physiology and thyroid malignancies.
    Philippe J; Dibner C
    J Biol Rhythms; 2015 Apr; 30(2):76-83. PubMed ID: 25411240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 4,4'-oxydianiline on the thyroid and pituitary glands of F344 rats: a morphologic study with the use of the immunoperoxidase method.
    Murthy AS; Russfield AB; Snow GJ
    J Natl Cancer Inst; 1985 Jan; 74(1):203-8. PubMed ID: 3881621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer.
    Foster JR; Tinwell H; Melching-Kollmuss S
    Arch Toxicol; 2021 Mar; 95(3):807-836. PubMed ID: 33398420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures.
    Chico Galdo V; Massart C; Jin L; Vanvooren V; Caillet-Fauquet P; Andry G; Lothaire P; Dequanter D; Friedman M; Van Sande J
    Mol Cell Endocrinol; 2006 Sep; 257-258():6-14. PubMed ID: 16859826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethyl acrylate (EA) exposure and thyroid carcinogenicity in rats and mice with relevance to human health.
    Rosol TJ; Witorsch RJ
    Regul Toxicol Pharmacol; 2021 Aug; 124():104961. PubMed ID: 34015422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammary gland neoplasia in long-term rodent studies.
    Russo IH; Russo J
    Environ Health Perspect; 1996 Sep; 104(9):938-67. PubMed ID: 8899375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of subchronic acrylamide exposure on gene expression, neurochemistry, hormones, and histopathology in the hypothalamus-pituitary-thyroid axis of male Fischer 344 rats.
    Bowyer JF; Latendresse JR; Delongchamp RR; Muskhelishvili L; Warbritton AR; Thomas M; Tareke E; McDaniel LP; Doerge DR
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):208-15. PubMed ID: 18430446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of thyroid and liver tumors by chronic exposure to 2-methylimidazole in F344/N rats and B6C3F1 mice.
    Chan PC; Sills RC; Kissling GE; Nyska A; Richter W
    Arch Toxicol; 2008 Jun; 82(6):399-412. PubMed ID: 17924096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicity profiles in rats treated with tumorigenic and nontumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil.
    Wolf DC; Allen JW; George MH; Hester SD; Sun G; Moore T; Thai SF; Delker D; Winkfield E; Leavitt S; Nelson G; Roop BC; Jones C; Thibodeaux J; Nesnow S
    Toxicol Pathol; 2006; 34(7):895-902. PubMed ID: 17178690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
    Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
    Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.